It makes ominous predictions about existing vaccines for him coronavirus and their effectiveness against the new Omicron mutation, its CEO Modern, Stephan Bancell.
Speaking to the Financial Times, the CEO of Moderna estimates that it is unlikely vaccines be as effective with the Homicron mutation as with previous strains of the virus.
It makes ominous predictions about existing vaccines for him coronavirus and their effectiveness against the new Omicron mutation, its CEO Modern, Stephan Bancell.
Speaking to the Financial Times, the CEO of Moderna estimates that it is unlikely vaccines be as effective with the Homicron mutation as with previous strains of the virus.
«There is no way, I think, to be as effective as it was with the Delta mutation. I think it will be noted significant reduction in efficiency. I just do not know how much, because we have to wait for the data. "But all the scientists I've talked to say that 'this is not good.'
Stephen Bancell also said that the large number of Omicron mutations in the spike protein used by the virus to infect human cells, and the rapid spread of the variant in South Africa, suggest that existing vaccines will need to be modified.